Uzm. Dr. Naciye Demirel

Primary Versus Secondary Warm Autoimmune Hemolytic Anemia: Clinical, Laboratory, and Treatment Outcomes in A 20-Year Retrospective Study

European Archives of Medical Research, 2026

DOI 10.14744/eamr.2025.68926 Frei zugänglicher VolltextQuelle: OpenAlex

Comparison of different response evaluation criteria in interim PET/CT for diffuse large B-cell lymphoma: is Δtotal metabolic tumor volume a worthwhile measure?

Nuclear Medicine Communications, 2025

DOI 10.1097/mnm.0000000000002047 PMID 40910350 Quelle: ORCID

The assessment of health-related quality of life in patients with polycythemia vera

Medicine, 2024

DOI 10.1097/md.0000000000038814 PMID 39058813 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Eş Zamanlı Multipl Miyelom ve Polisitemiya Vera Tanısı Konulan Nadir Bir Olgu

Akademisyen Kitabevi eBooks, 2024

DOI 10.37609/akya.2870.c11277 Quelle: OpenAlex

Charlson Comorbidity Index (CCI) in Diffuse Large B-cell Lymphoma: A New Approach in a Multicenter Study

Indian Journal of Hematology and Blood Transfusion, 2023

DOI 10.1007/s12288-022-01567-5 PMID 36186233 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

The Obesity Controversy: Does It Impact Treatment Response in Diffuse Large B-Cell Lymphoma?

International Journal of Hematology-Oncology and Stem Cell Research, 2023

DOI 10.18502/ijhoscr.v17i2.12643 PMID 37637766 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Factors associated with quality of life in caregivers of patients with multiple myeloma

Journal of Surgery and Medicine, 2023

DOI 10.28982/josam.8002 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

The Frequency of Transfusion Reactions in Acute Period: Single Center Study

Turkiye Klinikleri Journal of Internal Medicine, 2022

DOI 10.5336/intermed.2022-92571 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Survival in patients with multiple myeloma: evaluation of possible associations with bone marrow fibrosis and investigation of factors independently associated with survival

Bulletin of the National Research Centre/Bulletin of the National Research Center, 2022

DOI 10.1186/s42269-022-00926-6 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Examination of the need for treatment and the variables affecting survival in patients with chronic lymphocytic leukemia without indication for treatment at admission

Annals of Medical Research, 2022

DOI 10.5455/annalsmedres.2021.06.455 Frei zugänglicher VolltextQuelle: OpenAlex

COVID-19 ve Kanser

Akademisyen Kitabevi eBooks, 2021

DOI 10.37609/akya.668 Quelle: ORCID

Eltrombopag in the Treatment of Immune Thrombocytopenia: Two-Center Experience from Istanbul

Indian Journal of Hematology and Blood Transfusion, 2021

DOI 10.1007/s12288-021-01462-5 PMID 35496971 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Diffuse large B-cell lymphoma that develops after adalimumab using adalimumab in a patient with psoriasis

TURKDERM, 2021

DOI 10.4274/turkderm.galenos.2020.34356 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Treatment Outcomes in Hairy Cell Leukemia: Data of Patients in a Tertiary Referral Hospital in Turkey for Over 20 Years

Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy, 2021

DOI 10.4274/bmj.galenos.2021.85047 Frei zugänglicher VolltextQuelle: OpenAlex

An Unconventional Presentation of Multiple Myeloma: Bazex Syndrome

Turkish journal of haematology : official journal of Turkish Society of Haematology, 2020

DOI 10.4274/tjh.galenos.2020.2020.0308 PMID 32830932 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

How Does 2016 WHO Criteria for Polycythemia Vera Contribute to Our Daily Practice? A Single-Center Study from Turkey

International Journal of Hematology-Oncology and Stem Cell Research, 2020

DOI 10.18502/ijhoscr.v14i4.4478 PMID 33603984 5 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Chanarin-Dorfman syndrome

The Turkish Journal of Gastroenterology, 2018

DOI 10.5152/tjg.2018.18014 PMID 30457558 18 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Could neutrophil CD64 expression be used as a diagnostic parameter of bacteremia in patients with febrile neutropenia?,Nötrofil CD64 Ekspresyonu Febril Nötropenik Hastaların Bakteriyemisinde Tanı Kriteri Olarak Kullanılabilir mi?

Turkish Journal of Hematology, 2017

DOI 10.4274/tjh.2016.0123 PMID 27348760 4 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec

Clinical Lymphoma Myeloma and Leukemia, 2017

DOI 10.1016/j.clml.2017.07.255 PMID 28847475 15 Zitationen (Europe PMC) Quelle: ORCID

Novel Antifungal Drugs Against Fungal Pathogens: Do They Provide Promising Results for Treatment?

Indian Journal of Hematology and Blood Transfusion, 2015

DOI 10.1007/s12288-014-0370-8 PMID 25825558 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Which Multidrug-Resitant Bacteria are Emerging in Patients with Hematological Malignancies?: One-Year Report

Indian Journal of Hematology and Blood Transfusion, 2015

DOI 10.1007/s12288-014-0402-4 PMID 25548445 4 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Bloodstream infections in patients with hematological malignancies: Which is more fatal – Cancer or resistant pathogens?

Therapeutics and Clinical Risk Management, 2014

DOI 10.2147/tcrm.s68450 PMID 25258539 38 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Primary or secondary antifungal prophylaxis in patients with hematological maligancies: Efficacy and damage

Therapeutics and Clinical Risk Management, 2014

DOI 10.2147/tcrm.s59683 PMID 24855365 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Vancomycin-resistant enterococci colonization and bacteremia in patients with hematological malignancies

Journal of Infection in Developing Countries, 2014

DOI 10.3855/jidc.4451 PMID 25212075 12 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate

British Journal of Haematology, 2014

DOI 10.1111/bjh.12937 PMID 24815307 17 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

The outcome of non-carbapenem-based empirical antibacterial therapy and VRE colonisation in patients with hematological malignancies

African Health Sciences, 2013

DOI 10.4314/ahs.v13i2.24 PMID 24235937 7 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

When and which fungal pathogens should come to mind in patients with hematological malignancies

2013

1 Zitation (OpenAlex) Quelle: OpenAlex

Fungal pathogens and primary antifungal prophylaxis in patients with hematological malignancies: One year experience

African Health Sciences, 2012

DOI 10.4314/ahs.v12i3.23 PMID 23382758 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Does Previous Interferon Use Have Negative Effect on Imatinib Response in Chronic Myeloid Leukemia (CML)? A Single Center Study.

Blood, 2006

DOI 10.1182/blood.v108.11.4821.4821 Quelle: OpenAlex